Herpes Zoster vaccine (Innorna)

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameHerpes Zoster vaccine (Innorna)
Drug Alias Name带状疱疹IN001 mRNA疫苗IN-001(Innorna)IN001(Innorna)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes ZosterVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInnorna Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnorna Co Ltd
Inactive CompaniesN/A
Active IndicationsHerpes ZosterVaricella Zoster Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A